Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei infection, 2010

Rebecca Lipsitz, Susan Garges, Rosemarie Aurigemma, Prasith Baccam, David D Blaney, Allen Cheuk-Seng Cheng, Bart J Currie, David A B Dance, Jay E Gee, Joseph C Larsen, Direk Limmathurotsakul, Meredith G Morrow, Robert Norton, Elizabeth O'Mara, Sharon J Peacock, Nicki T Pesik, L Paige Rogers, Herbert P Schweizer, Ivo Steinmetz, Gladys Gek Yen TanPatrick Tan, W J Wiersinga, Vannaporn Wuthiekanun, Terry L Smith

Research output: Contribution to journalArticleOther

147 Citations (Scopus)


The US Public Health Emergency Medical Countermeasures Enterprise convened subject matter experts at the 2010 HHS Burkholderia Workshop to develop consensus recommendations for postexposure prophylaxis against and treatment for Burkholderia pseudomallei and B. mallei infections, which cause melioidosis and glanders, respectively. Drugs recommended by consensus of the participants are ceftazidime or meropenem for initial intensive therapy, and trimethoprim/sulfamethoxazole or amoxicillin/clavulanic acid for eradication therapy. For postexposure prophylaxis, recommended drugs are trimethoprim/sulfamethoxazole or co-amoxiclav. To improve the timely diagnosis of melioidosis and glanders, further development and wide distribution of rapid diagnostic assays were also recommended. Standardized animal models and B. pseudomallei strains are needed for further development of therapeutic options. Training for laboratory technicians and physicians would facilitate better diagnosis and treatment options.
Original languageEnglish
Pages (from-to)e2
Number of pages1
JournalEmerging Infectious Diseases
Issue number12
Publication statusPublished - 2012

Cite this